Dr. Vincent DeVita Honored by ASCO with Top Advance in 50 Years of Modern Oncology
Congratulations to Dr. Vincent DeVita, the Amy and Joseph Perella Professor of Medical Oncology and former Director of Yale Cancer Center, who received the prestigious honor of having developed the treatment for Hodgkins Disease, MOPP, which was voted as the Top Advance in 50 Years of Modern Oncology by the American Society of Clinical Oncology (ASCO).
Discovered by Dr. DeVita in 1965, MOPP was the first chemotherapy breakthrough for advanced cancer in adults. The four-drug combination chemotherapy regimen induced long-term remissions in over half of patients with aggressive Hodgkins lymphoma. Dr. DeVita's breakthrough sparked the first hope that advanced cancers could be cured with drug treatment, and paved the way for 90% cure rates for patients with this disease today.
Congratulations to Dr. DeVita! Learn More >> http://bit.ly/1uJpL5b
This article was submitted by Renee Elizabeth Gaudette on September 26, 2014.